Scantox Ballerup ApS: Financial statements 2022
CVR: 34724938
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Scantox Ballerup ApS (CVR 34724938) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 14,086,064 and a net result of DKK 4,686,358 compared with DKK 2,325,348 the year before. That is an increase of 46.4% compared with the year before. Equity in the 2022 report amounted to DKK 9,964,428. The solvency ratio was 76.5%. The company had 9 employees in the financial year.
- Gross Profit
- DKK 14,086,064
- Profit/Loss
- DKK 4,686,358
- Equity
- DKK 9,964,428
- Total Assets
- DKK 13,024,695
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 14.1M | 4.7M | 10M | 9 |
| 2021 | - | 9.6M | 2.3M | 7.1M | 8 |
| 2020 | - | 6.3M | 287K | 5M | 7 |
| 2019 | - | 6.7M | 830K | 4.8M | 7 |
| 2018 | - | 4.9M | -195K | 4.1M | 7 |
Official annual report
Keep an eye on Scantox Ballerup ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Scantox Ballerup ApS has published its annual report for 2021. Gross profit came to DKK 9,621,992, and the net result was DKK 2,325,348.
As of February 23, 2022, Michael Ryding has been appointed auditor of Scantox Ballerup ApS.
As of February 23, 2022, NEJSTGAARD & VETLOV, GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Scantox Ballerup ApS.
About Scantox Ballerup ApS
Scantox Ballerup ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SOLURAL PHARMA ApS. The management consists of Helle Kirstein Erichsen. The board consists of Jeanet Løgsted Nielsen (chair) and Emil Staal Bergander. The company is owned by Scantox Denmark ApS. The company has 14 employees (2026). In 2025, the company reported a gross profit of DKK 13,349,106 and a net result of DKK -1,931,049 compared with DKK 255,010 the year before. Equity in the 2025 report amounted to DKK -1,539,321.